Stetson Van Matre1, Evan Hicks1, Gresham T Richter1,2
1Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Topical sirolimus shows promise for treating agminated pyogenic granulomas (PGs). This mTOR inhibitor effectively reduced size, color, and bleeding in two patients with this challenging vascular tumor.
Area of Science:
Background: